🇺🇸 FDA
Patent

US 10188714

Yeast-MUC1 immunotherapeutic compositions and uses thereof

granted A61KA61K2039/523A61K2039/525

Quick answer

US patent 10188714 (Yeast-MUC1 immunotherapeutic compositions and uses thereof) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/523, A61K2039/525, A61K2039/6031, A61K31/65